David Turkaly
Stock Analyst at Citizens JMP
(0.25)
# 4,364
Out of 4,575 analysts
456
Total ratings
39.1%
Success rate
-4.1%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintained: Buy | $85 → $115 | $104.82 | +9.71% | 21 | May 8, 2026 | |
| MDXG MiMedx Group | Maintained: Buy | $7 → $6 | $4.20 | +42.86% | 3 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Buy | $125 → $105 | $91.35 | +14.94% | 29 | Apr 29, 2026 | |
| AXGN Axogen | Maintained: Buy | $42 → $50 | $39.49 | +26.61% | 30 | Apr 29, 2026 | |
| TELA TELA Bio | Maintained: Buy | $5 → $3 | $0.691 | +334.15% | 23 | Mar 27, 2026 | |
| SYK Stryker | Upgraded: Buy | $440 | $330.25 | +33.23% | 21 | Dec 19, 2025 | |
| APYX Apyx Medical | Upgraded: Buy | $8 | $3.92 | +104.08% | 34 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Maintained: Buy | $35 → $25 | $18.87 | +32.49% | 37 | Oct 10, 2025 | |
| GMED Globus Medical | Reiterated: Hold | n/a | $76.49 | - | 24 | Aug 20, 2025 | |
| IART Integra LifeSciences Holdings | Reiterated: Buy | $25 | $19.79 | +26.33% | 31 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.73 | +304.62% | 23 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $78.78 | n/a | 33 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $280 | $214.07 | n/a | 40 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.99 | n/a | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $55 | $27.03 | n/a | 4 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $16.62 | n/a | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $132.10 | n/a | 24 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.25 | n/a | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.19 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $80.54 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.65 | n/a | 2 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $9.74 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.97 | n/a | 1 | Jun 25, 2009 |
Lantheus Holdings
May 8, 2026
Maintained: Buy
Price Target: $85 → $115
Current: $104.82
Upside: +9.71%
MiMedx Group
Apr 30, 2026
Maintained: Buy
Price Target: $7 → $6
Current: $4.20
Upside: +42.86%
Zimmer Biomet Holdings
Apr 29, 2026
Maintained: Buy
Price Target: $125 → $105
Current: $91.35
Upside: +14.94%
Axogen
Apr 29, 2026
Maintained: Buy
Price Target: $42 → $50
Current: $39.49
Upside: +26.61%
TELA Bio
Mar 27, 2026
Maintained: Buy
Price Target: $5 → $3
Current: $0.691
Upside: +334.15%
Stryker
Dec 19, 2025
Upgraded: Buy
Price Target: $440
Current: $330.25
Upside: +33.23%
Apyx Medical
Nov 12, 2025
Upgraded: Buy
Price Target: $8
Current: $3.92
Upside: +104.08%
OrthoPediatrics
Oct 10, 2025
Maintained: Buy
Price Target: $35 → $25
Current: $18.87
Upside: +32.49%
Globus Medical
Aug 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $76.49
Upside: -
Integra LifeSciences Holdings
Aug 1, 2025
Reiterated: Buy
Price Target: $25
Current: $19.79
Upside: +26.33%
Jul 28, 2025
Reiterated: Buy
Price Target: $7
Current: $1.73
Upside: +304.62%
May 20, 2025
Reiterated: Buy
Price Target: $100
Current: $78.78
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $265 → $280
Current: $214.07
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $24.99
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $62 → $55
Current: $27.03
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $32
Current: $16.62
Upside: n/a
Apr 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $132.10
Upside: n/a
Mar 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.25
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.19
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $80.54
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $8.65
Upside: n/a
Jun 3, 2016
Reiterated: Buy
Price Target: $17
Current: $9.74
Upside: n/a
Jun 25, 2009
Downgraded: Hold
Price Target: n/a
Current: $3.97
Upside: n/a